NEKTAR THERAPEUTICS (NKTR) FY2026 Q2 Balance Sheet

NEKTAR THERAPEUTICS (NKTR) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

1,095,129,000 US dollars

Current assets

739,402,000 US dollars

Non-current assets

355,727,000 US dollars

Liabilities

192,008,000 US dollars

Current liabilities

70,985,000 US dollars

Non-current liabilities

121,023,000 US dollars

Equity

903,121,000 US dollars

Short-term investments

645,074,000 US dollars

Other current assets (including $0 and $429 as of June 30, 2026 and December 31, 2025, respectively, from a related party)

55,061,000 US dollars

Cash and cash equivalents

39,267,000 US dollars

Long-term investments

339,061,000 US dollars

Other assets

16,666,000 US dollars

Accounts payable (including $456 and $137 as of June 30, 2026 and December 31, 2025, respectively, to a related party)

24,891,000 US dollars

Accrued expenses (including $130 and $994 as of June 30, 2026 and December 31, 2025, respectively, to a related party)

23,388,000 US dollars

Operating lease liabilities, current portion

22,706,000 US dollars

Liabilities related to the sales of future royalties, net

57,378,000 US dollars

Operating lease liabilities, less current portion

55,850,000 US dollars

Other long-term liabilities

7,795,000 US dollars

Capital in excess of par value

4,750,686,000 US dollars

Common stock, $0.0001 par value; 390,000,000 shares authorized; 34,129,664 shares and 20,378,832 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

3,000 US dollars

Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares designated or outstanding at June 30, 2026 or December 31, 2025, respectively

0 US dollars

Accumulated deficit

negative 3,845,812,000 US dollars

Accumulated other comprehensive income (loss)

negative 1,756,000 US dollars

Gross equity (calculated)

4,750,689,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.